The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Sep 2023 07:00

RNS Number : 2324M
Duke Royalty Limited
13 September 2023
 

13 September 2023

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Trading Update

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to provide the following trading and operational update for its first quarter of the financial year 2024, ending 30 June 2023 ("Q1 FY24"). The Company also provides guidance on trading for its second quarter, ending 30 September 2023 ("Q2 FY24").

 

Q1 FY24 Financial Highlights:

 

· Recurring cash revenue for Q1 FY24 reached a new record of £6.0 million, an increase of 17% over Q1 FY23, and a £300,000 increase on the prior quarter

· The £6.0 million for the quarter meant Duke delivered an average monthly recurring cash revenue of £2.0 million for the first time in the Company's history, a significant milestone

· Q1 FY24 total cash revenue reached £7.8 million, marking another quarterly cash revenue record, surpassing the previous record of £6.7 million in Q4 FY22, on account of the Instor buyback

· 0.70p interim dividend paid out in April 2023

Overview of quarterly revenue growth:

 

Recurring Cash Revenue*

Total Cash Revenue**

Q1 FY23

£5.1 million

£5.1 million

Q2 FY23

£5.3 million

£5.3 million

Q3 FY23

£5.6 million

£5.6 million

Q4 FY23

£5.7 million

£5.8 million

Q1 FY24

£6.0 million

£7.8 million

 

* Recurring cash revenue excludes buyback premium receipts and cash gains from equity sales

** Total cash revenue is monthly cash distributions from Duke's royalty partners plus cash gains received from the sales of equity assets and buyback premiums

 

 

Q1 FY24 Operational Highlights:

· In May 2023, Duke announced the successful exit of its investment in royalty partner Instor Solutions, Inc. Duke received net cash of US$11.2 million at closing, delivering a total gain of US$2.4 million and a triple-digit IRR

· Duke also completed two material follow-on investments in the quarter as follows:

- a £1.9 million investment into New Path Fire and Security to facilitate its acquisition of BDI Security Limited

- a £1.8 million investment int Tristone Healthcare to enable the company to complete its acquisition of South West Intervention Service Limited

 

Financial Forecast for Q2 FY24:

 

· Based on current trading, Duke expects to achieve recurring cash revenue of £6.2 million in Q2 FY24

· The £6.2 million of cash revenue would represent a 17% year-on-year increase (Q2 FY23: £5.3 million) and a further increase on Q1 FY24

 

Neil Johnson, CEO of Duke Royalty, said:

 

"We are pleased to report another quarter marked by record-breaking cash performance, underpinned by solid growth. This underscores the resilience of Duke's business model, especially in the face of ongoing economic challenges. Looking ahead, we remain confident that the consistent quarterly growth we have generated in recurring revenue will continue, and Duke is committed to working with our partners for their long-term growth."

 

Change of Name of Nominated Adviser and Joint Broker

 

The Company also announces that its Nominated Adviser and Joint Broker has changed its name to Cavendish Securities plc following completion of its own corporate merger.

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

 

Duke Royalty Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

 

+44 (0) 1481 730 613

Cavendish Securities plc 

(Nominated Adviser

and Joint Broker)

 

Stephen Keys / Callum Davidson / Michael Johnson

 

+44 (0) 207 397 8900

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Alice Cho / Matthew Elliott

+44 (0) 20 3757 6882 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLLLFXKLBBBB
Date   Source Headline
9th Dec 20145:23 pmRNSNet Asset Value
3rd Nov 20147:00 amRNSChange of administrator and registered address
22nd Oct 20147:00 amRNSNet Asset Value(s)
20th Aug 20141:54 pmRNSResult of AGM
24th Jul 20147:00 amRNSNet Asset Value(s)
16th Jul 201410:11 amRNSHolding(s) in Company
15th Jul 20147:00 amRNSHolding(s) in Company
30th Jun 20147:00 amRNSIssue of Equity
27th Jun 201412:30 pmRNSResults for the year ended 31 March 2014
9th Jun 201410:08 amRNSBoard Changes and change of Nominated Adviser
6th May 201410:53 amRNSBuy-Back of Shares
25th Apr 20143:36 pmRNSOperational update
14th Apr 20142:24 pmRNSNet Asset Value(s)
28th Mar 20144:18 pmRNSHolding(s) in Company
6th Feb 20147:00 amRNSDirector/PDMR Shareholding
22nd Jan 20147:00 amRNSNet Asset Value(s)
12th Dec 201311:36 amRNSInterim Results
30th Oct 20137:00 amRNSFundraising of £1.5 million
29th Oct 20137:00 amRNSForm 8.3 - Equatorial Palm Oil plc
15th Oct 20137:00 amRNSNet Asset Value(s) at 30 September 2013
22nd Aug 20132:14 pmRNSResult of AGM
5th Aug 20134:29 pmRNSIssue of Equity
25th Jul 20137:00 amRNSPreliminary Final Results
19th Jul 20133:24 pmRNSNet Asset Value(s)
28th Jun 20133:15 pmRNSHolding(s) in Company
28th Jun 20139:37 amRNSHolding(s) in Company
28th Jun 20137:00 amRNSDirectorate Change
23rd Apr 201311:16 amRNSReplacement - Net Asset Value
23rd Apr 20137:00 amRNSNet Asset Value(s)
16th Apr 20133:18 pmRNSBuyback of ordinary shares
27th Mar 20133:58 pmRNSDirector/PDMR Shareholding
18th Jan 20137:00 amRNSNet Asset Value(s)
21st Dec 20123:06 pmRNSHalf Yearly Report
22nd Nov 20125:00 pmRNSCancellation of Equity
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
22nd Oct 20127:00 amRNSNet Asset Value(s)
1st Oct 20127:00 amRNSTotal Voting Rights
27th Sep 201212:32 pmRNSHolding(s) in Company
20th Sep 201210:36 amRNSCompletion of Investment in Ausgold Limited
23rd Aug 20121:15 pmRNSDirector/PDMR Shareholding
6th Aug 201211:49 amRNSAusgold Limited - Share Exchange and Subscription
1st Aug 201212:00 pmRNSTotal Voting Rights
30th Jul 201210:15 amRNSCompletion Mantle Diamonds Tfr & Share Exch
27th Jul 201212:00 pmRNSCompletion of Subscription by Longships plc
11th Jul 20124:03 pmRNSHolding(s) in Company
9th Jul 20127:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.